Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: Analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial

Yanai Ben-Gal, Jeffrey W. Moses, Roxana Mehran, Alexandra J. Lansky, Giora Weisz, Eugenia Nikolsky, Michael Argenziano, Matthew R. Williams, Antonio Colombo, Philip E. Aylward, Gregg W. Stone

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives The aim of this study was to evaluate outcomes of patients with moderate- and high-risk acute coronary syndromes (ACS) and multivessel coronary artery disease managed with percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). Background There is uncertainty about the preferred revascularization strategy for high-risk patients with multivessel disease. Methods Among 13,819 moderate- and high-risk ACS patients enrolled in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial, 5,627 had multivessel disease (including left anterior descending artery involvement) and were managed by PCI (n = 4,412) or CABG (n = 1,215). Propensity score matching was applied to adjust for differences in baseline clinical and angiographic characteristics, yielding a total of 1,056 patients (528 managed by PCI, and 528 managed by CABG). Results Propensity-matched patients undergoing CABG had higher 1-month rates of stroke (1.1% vs. 0.0%, p = 0.03) and myocardial infarction (13.3% vs. 8.8%, p = 0.03), received more blood transfusions (40.3% vs. 6.3%, p <0.0001) and more frequently developed acute renal injury (31.7% vs. 14.2%, p <0.0001), whereas PCI was associated with higher rates of unplanned revascularization at both 1 month and at 1 year (0.8% vs. 5.2%, p <0.0001; and 3.8% vs. 16.5%, p <0.0001, respectively). There were no significant differences between the CABG and PCI groups in 1-month or 1-year mortality (2.5% vs. 2.1%, p = 0.69; and 4.4% vs. 5.7%, p = 0.58, respectively). Conclusions In this propensity-matched comparison from the ACUITY trial, moderate- and high-risk patients with ACS and multivessel disease treated with PCI rather than CABG had lower rates of peri-procedural stroke, myocardial infarction, major bleeding, and renal injury, with comparable 1-month and 1-year rates of mortality, but more frequently developed recurrent ischemia requiring repeat revascularization procedures during follow-up. (Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes [ACS]; NCT00093158)

Original languageEnglish
Pages (from-to)1059-1067
Number of pages9
JournalJACC: Cardiovascular Interventions
Volume3
Issue number10
DOIs
Publication statusPublished - Oct 2010

Keywords

  • ACS
  • acute coronary syndrome
  • CABG
  • coronary artery bypass grafting
  • multivessel coronary disease
  • PCI
  • percutaneous coronary intervention.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: Analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial'. Together they form a unique fingerprint.

Cite this